Publication: Step-Up and Step-Down Treatment Approaches for COPD: A Holistic View of Progressive Therapies.
Loading...
Identifiers
Date
2021-07-12
Authors
Lopez-Campos, Jose Luis
Carrasco-Hernandez, Laura
Ruiz-Duque, Borja
Reinoso-Arija, Rocio
Caballero-Eraso, Candelaria
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Dove Medical Press Ltd.
Abstract
Recent advances in inhaled drugs and a clearer definition of the disease have made the task of managing COPD more complex. Different proposals have been put forward which combine all the available treatments and the different clinical presentations in an effort to select the best therapeutic options for each clinical context. As COPD is a chronic progressive disease, the escalation of therapy has traditionally been considered the most natural way to tackle it. However, the notion of COPD as a constantly progressing disease has recently been challenged and, in specific areas, this points to the possibility of a de-escalation in treatment. In this context, the clinician requires simple, specific recommendations to guide these changes in treatment in their daily clinical practice. To accomplish this, the first step must be a correct evaluation and an accurate initial preliminary diagnosis of the patient's condition. Thereafter, the first escalation in therapy must be introduced with caution as the disease progresses, since clinical trials are not designed with clinical decision-making in mind. During this escalation, three possibilities are open to change the current treatment for a different one within the same family, to increase non-pharmacological interventions or to increase the pharmacological therapies. Beyond that point, a patient with persistent symptoms represents a complex clinical scenario which requires a specialized approach, including the evaluation of different respiratory and non-respiratory comorbidities. Unfortunately, there are few de-escalation studies available, and these are mainly observational in nature. The debate on de-escalation in pharmacological treatment, therefore, involves two main discussion points: the withdrawal of bronchodilators and the withdrawal of inhaled steroids. Altogether, the scheme for modifying treatment must be more personalized than just adding molecules, and the therapeutic response and its conditioning factors should be evaluated at each step before proceeding further.
Description
MeSH Terms
Administration, Inhalation
Adrenal Cortex Hormones
Bronchodilator Agents
Comorbidity
Humans
Pulmonary Disease, Chronic Obstructive
Adrenal Cortex Hormones
Bronchodilator Agents
Comorbidity
Humans
Pulmonary Disease, Chronic Obstructive
DeCS Terms
Terapéutica
Enfermedad Pulmonar Obstructiva Crónica
Diagnóstico
Esteroides
Broncodilatadores
Preparaciones farmacéuticas
Familia
Enfermedad Pulmonar Obstructiva Crónica
Diagnóstico
Esteroides
Broncodilatadores
Preparaciones farmacéuticas
Familia
CIE Terms
Keywords
COPD, escalation of treatment, pharmacological therapies, precision medicine
Citation
López-Campos JL, Carrasco Hernández L, Ruiz-Duque B, Reinoso-Arija R, Caballero-Eraso C. Step-Up and Step-Down Treatment Approaches for COPD: A Holistic View of Progressive Therapies. Int J Chron Obstruct Pulmon Dis. 2021 Jul 12;16:2065-2076.